Still, many in the performance and injury rehab communities use BPC-157 off-label for: Chronic tendinopathies Joint degeneration Gut permeability Accelerated post-surgery rehab "Despite limited clinical trials, the number of consistent anecdotal reports and supporting animal research is what drives interest in BPC-157," notes Irrgang and colleagues, Orthopaedic Journal of Sports Medicine
105 (ed
Why standard dosing ranges exist The 300-500mcg daily range did not appear arbitrarily
Runners are most familiar with shin splints, but athletes in many other disciplines can experience them, too
The peptide successfully heals internal fistulas (gastrocutaneous, duodenocutaneous, and colocutaneous) in experimental models, achieving fistula closure even when treatment is delayed for one month after fistula formation
It's important to note that despite these promising animal study results, the lack of robust human data presents a significant caveat